Cargando…

The extracellular matrix of mycobacterial biofilms: could we shorten the treatment of mycobacterial infections?

A number of non-tuberculous mycobacterium species are opportunistic pathogens and ubiquitously form biofilms. These infections are often recalcitrant to treatment and require therapy with multiple drugs for long duration. The biofilm resident bacteria also display phenotypic drug tolerance and thus...

Descripción completa

Detalles Bibliográficos
Autores principales: Chakraborty, Poushali, Kumar, Ashwani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shared Science Publishers OG 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6364259/
https://www.ncbi.nlm.nih.gov/pubmed/30740456
http://dx.doi.org/10.15698/mic2019.02.667
_version_ 1783393233371398144
author Chakraborty, Poushali
Kumar, Ashwani
author_facet Chakraborty, Poushali
Kumar, Ashwani
author_sort Chakraborty, Poushali
collection PubMed
description A number of non-tuberculous mycobacterium species are opportunistic pathogens and ubiquitously form biofilms. These infections are often recalcitrant to treatment and require therapy with multiple drugs for long duration. The biofilm resident bacteria also display phenotypic drug tolerance and thus it has been hypothesized that the drug unresponsiveness in vivo could be due to formation of biofilms inside the host. We have discussed the biofilms of several pathogenic non-tuberculous mycobacterium (NTM) species in context to the in vivo pathologies. Besides pathogenic NTMs, Mycobacterium smegmatis is often used as a model organism for understanding mycobacterial physiology and has been studied extensively for understanding the mycobacterial biofilms. A number of components of the mycobacterial cell wall such as glycopeptidolipids, short chain mycolic acids, monomeromycolyl diacylglycerol, etc. have been shown to play an important role in formation of pellicle biofilms. It shall be noted that these components impart a hydrophobic character to the mycobacterial cell surface that facilitates cell to cell interaction. However, these components are not necessarily the constituents of the extracellular matrix of mycobacterial biofilms. In the end, we have described the biofilms of Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis. Three models of Mtb biofilm formation have been proposed to study the factors regulating biofilm formation, the physiology of the resident bacteria, and the nature of the biomaterial that holds these bacterial masses together. These models include pellicle biofilms formed at the liquid-air interface of cultures, leukocyte lysate-induced biofilms, and thiol reductive stressinduced biofilms. All the three models offer their own advantages in the study of Mtb biofilms. Interestingly, lipids (mainly keto-mycolic acids) are proposed to be the primary component of extracellular polymeric substance (EPS) in the pellicle biofilm, whereas the leukocyte lysate-induced and thiol reductive stress-induced biofilms possess polysaccharides as the primary component of EPS. Both models also contain extracellular DNA in the EPS. Interestingly, thiol reductive stressinduced Mtb biofilms are held together by cellulose and yet unidentified structural proteins. We believe that a better understanding of the EPS of Mtb biofilms and the physiology of the resident bacteria will facilitate the development of shorter regimen for TB treatment.
format Online
Article
Text
id pubmed-6364259
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Shared Science Publishers OG
record_format MEDLINE/PubMed
spelling pubmed-63642592019-02-08 The extracellular matrix of mycobacterial biofilms: could we shorten the treatment of mycobacterial infections? Chakraborty, Poushali Kumar, Ashwani Microb Cell Review A number of non-tuberculous mycobacterium species are opportunistic pathogens and ubiquitously form biofilms. These infections are often recalcitrant to treatment and require therapy with multiple drugs for long duration. The biofilm resident bacteria also display phenotypic drug tolerance and thus it has been hypothesized that the drug unresponsiveness in vivo could be due to formation of biofilms inside the host. We have discussed the biofilms of several pathogenic non-tuberculous mycobacterium (NTM) species in context to the in vivo pathologies. Besides pathogenic NTMs, Mycobacterium smegmatis is often used as a model organism for understanding mycobacterial physiology and has been studied extensively for understanding the mycobacterial biofilms. A number of components of the mycobacterial cell wall such as glycopeptidolipids, short chain mycolic acids, monomeromycolyl diacylglycerol, etc. have been shown to play an important role in formation of pellicle biofilms. It shall be noted that these components impart a hydrophobic character to the mycobacterial cell surface that facilitates cell to cell interaction. However, these components are not necessarily the constituents of the extracellular matrix of mycobacterial biofilms. In the end, we have described the biofilms of Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis. Three models of Mtb biofilm formation have been proposed to study the factors regulating biofilm formation, the physiology of the resident bacteria, and the nature of the biomaterial that holds these bacterial masses together. These models include pellicle biofilms formed at the liquid-air interface of cultures, leukocyte lysate-induced biofilms, and thiol reductive stressinduced biofilms. All the three models offer their own advantages in the study of Mtb biofilms. Interestingly, lipids (mainly keto-mycolic acids) are proposed to be the primary component of extracellular polymeric substance (EPS) in the pellicle biofilm, whereas the leukocyte lysate-induced and thiol reductive stress-induced biofilms possess polysaccharides as the primary component of EPS. Both models also contain extracellular DNA in the EPS. Interestingly, thiol reductive stressinduced Mtb biofilms are held together by cellulose and yet unidentified structural proteins. We believe that a better understanding of the EPS of Mtb biofilms and the physiology of the resident bacteria will facilitate the development of shorter regimen for TB treatment. Shared Science Publishers OG 2019-01-18 /pmc/articles/PMC6364259/ /pubmed/30740456 http://dx.doi.org/10.15698/mic2019.02.667 Text en https://creativecommons.org/licenses/by/4.0/ This is an open-access article released under the terms of the Creative Commons Attribution (CC BY) license, which allows the unrestricted use, distribution, and reproduction in any medium, provided the original author and source are acknowledged.
spellingShingle Review
Chakraborty, Poushali
Kumar, Ashwani
The extracellular matrix of mycobacterial biofilms: could we shorten the treatment of mycobacterial infections?
title The extracellular matrix of mycobacterial biofilms: could we shorten the treatment of mycobacterial infections?
title_full The extracellular matrix of mycobacterial biofilms: could we shorten the treatment of mycobacterial infections?
title_fullStr The extracellular matrix of mycobacterial biofilms: could we shorten the treatment of mycobacterial infections?
title_full_unstemmed The extracellular matrix of mycobacterial biofilms: could we shorten the treatment of mycobacterial infections?
title_short The extracellular matrix of mycobacterial biofilms: could we shorten the treatment of mycobacterial infections?
title_sort extracellular matrix of mycobacterial biofilms: could we shorten the treatment of mycobacterial infections?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6364259/
https://www.ncbi.nlm.nih.gov/pubmed/30740456
http://dx.doi.org/10.15698/mic2019.02.667
work_keys_str_mv AT chakrabortypoushali theextracellularmatrixofmycobacterialbiofilmscouldweshortenthetreatmentofmycobacterialinfections
AT kumarashwani theextracellularmatrixofmycobacterialbiofilmscouldweshortenthetreatmentofmycobacterialinfections
AT chakrabortypoushali extracellularmatrixofmycobacterialbiofilmscouldweshortenthetreatmentofmycobacterialinfections
AT kumarashwani extracellularmatrixofmycobacterialbiofilmscouldweshortenthetreatmentofmycobacterialinfections